Neurobiology of early psychosis

Background Neurobiological studies of the early course of psychoses, such as schizophrenia, allow investigation of pathophysiology without the confounds of illness chronicity and treatment. Aims To review the recent literature on the biology of the early course of psychoses. Method We carried out a critical appraisal of the recent findings in the neurobiology of early psychoses, using structural, functional and neurochemical imaging techniques. Results Brain structural alterations are present early in the illness and may predate symptom onset. Some changes, notably those in frontal and temporal lobes, can progress during the early phases of the illness. Functional and neurochemical brain abnormalities can also be seen in the premorbid and the early phases of the illness. Some, although not all, changes can be trait-like whereas some others might progress during the early years. Conclusions A better understanding of such changes, especially during the critical periods of the prodrome, around the transition to the psychotic phase and during the early phases of the illness is crucial for continued research into preventive intervention strategies.

[1]  W. Heiden,et al.  Course and Outcome of Schizophrenia , 2007 .

[2]  C. Pantelis,et al.  Impairment of olfactory identification ability in individuals at ultra-high risk for psychosis who later develop schizophrenia. , 2003, The American journal of psychiatry.

[3]  C. Pantelis,et al.  Spatial working memory ability is a marker of risk-for-psychosis , 2003, Psychological Medicine.

[4]  M. Yücel,et al.  Early and Late Neurodevelopmental Disturbances in Schizophrenia and Their Functional Consequences , 2003, The Australian and New Zealand journal of psychiatry.

[5]  Hans Stassen,et al.  How specific are deficits in mismatch negativity generation to schizophrenia? , 2003, Biological Psychiatry.

[6]  D. Nutt,et al.  Increased sympathetic response to standing in panic disorder , 2003, Psychiatry Research.

[7]  W. Strik,et al.  Reduced hippocampal anisotropy related to anteriorization of alpha EEG in schizophrenia , 2003, Neuroreport.

[8]  J. Callicott An expanded role for functional neuroimaging in schizophrenia , 2003, Current Opinion in Neurobiology.

[9]  S. Catts Book Review: Implementing Early Intervention in Psychosis: A Guide to Establishing Early Psychosis Services , 2003 .

[10]  S. Andersen Trajectories of brain development: point of vulnerability or window of opportunity? , 2003, Neuroscience & Biobehavioral Reviews.

[11]  C. Pantelis,et al.  Verbal paired associate learning in schizophrenia, schizophreniform psychosis and ‘at risk’ mental state , 2003, Schizophrenia Research.

[12]  J. Lieberman,et al.  Antipsychotic treatment effects on progression of brain pathomorphology in first episode schizophrenia , 2003, Schizophrenia Research.

[13]  Hok Pan Yuen,et al.  Psychosis prediction: 12-month follow up of a high-risk (“prodromal”) group , 2003, Schizophrenia Research.

[14]  C. Pantelis,et al.  Progressive frontal lobe reduction in first episode psychosis , 2003, Schizophrenia Research.

[15]  C. Pantelis,et al.  Melbourne high risk study: Olfactory identification ability is impaired in individuals at ultra high-risk for psychosis who later develop schizophrenia , 2003, Schizophrenia Research.

[16]  R. Heinrichs,et al.  Quantification of frontal and temporal lobe brain-imaging findings in schizophrenia: a meta-analysis , 2003, Psychiatry Research: Neuroimaging.

[17]  John Suckling,et al.  For personal use. Only reproduce with permission from The Lancet Publishing Group. Effect of sunlight and season on serotonin turnover in the brain , 2002 .

[18]  C. Pantelis,et al.  Prediction and prevention of transition to psychosis in young people at incipient risk for schizophrenia. , 2002, American journal of medical genetics.

[19]  B. Cornblatt The New York high risk project to the Hillside recognition and prevention (RAP) program. , 2002, American journal of medical genetics.

[20]  M. Keshavan,et al.  Decreased left amygdala and hippocampal volumes in young offspring at risk for schizophrenia , 2002, Schizophrenia Research.

[21]  Ravi S. Menon,et al.  Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers. , 2002, The American journal of psychiatry.

[22]  R. Kahn,et al.  Brain volume changes in first-episode schizophrenia: a 1-year follow-up study. , 2002, Archives of general psychiatry.

[23]  Beatriz Luna,et al.  A preliminary functional magnetic resonance imaging study in offspring of schizophrenic parents , 2002, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[24]  Hok Pan Yuen,et al.  Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. , 2002, Archives of general psychiatry.

[25]  P. Michie,et al.  Duration mismatch negativity in biological relatives of patients with schizophrenia spectrum disorders , 2002, Biological Psychiatry.

[26]  J. Klosterkötter,et al.  Subjective and objective neuropsychological abnormalities in a psychosis prodrome clinic , 2002, British Journal of Psychiatry.

[27]  Martha E Shenton,et al.  Mismatch negativity in chronic schizophrenia and first-episode schizophrenia. , 2002, Archives of general psychiatry.

[28]  Daniel R Weinberger,et al.  Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain? , 2002, Archives of general psychiatry.

[29]  Brian Sheitman,et al.  Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. , 2002, The American journal of psychiatry.

[30]  C. Pantelis,et al.  Implications of Lipid Biology for the Pathogenesis of Schizophrenia , 2002, The Australian and New Zealand journal of psychiatry.

[31]  Richie Poulton,et al.  Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. , 2002, Archives of general psychiatry.

[32]  C. Pantelis,et al.  Visuospatial memory and learning in first-episode schizophreniform psychosis and established schizophrenia: a functional correlate of hippocampal pathology? , 2002, Psychological Medicine.

[33]  Sandeep D. Jaipurkar,et al.  Structural brain differences between never-treated patients with schizophrenia, with and without dyskinesia, and normal control subjects: a magnetic resonance imaging study. , 2002, Archives of general psychiatry.

[34]  W. Heiden,et al.  Precipitation and determination of the onset and course of schizophrenia by substance abuse — a retrospective and prospective study of 232 population-based first illness episodes , 2002, Schizophrenia Research.

[35]  Ron Kikinis,et al.  Association between smaller left posterior superior temporal gyrus volume on magnetic resonance imaging and smaller left temporal P300 amplitude in first-episode schizophrenia. , 2002, Archives of general psychiatry.

[36]  P. McGorry,et al.  Implementing Early Intervention in Psychosis: A Guide to Establishing Psychosis Services , 2002 .

[37]  Dennis Velakoulis,et al.  Anterior cingulate activation during Stroop task performance: a PET to MRI coregistration study of individual patients with schizophrenia. , 2002, The American journal of psychiatry.

[38]  S. Lawrie,et al.  Sustained attention in young people at high risk for schizophrenia , 2002, Psychological Medicine.

[39]  S. Lawrie,et al.  Schizotypal components in people at high risk of developing schizophrenia: early findings from the Edinburgh High-Risk Study , 2002, British Journal of Psychiatry.

[40]  R. Kahn,et al.  Volume changes in gray matter in patients with schizophrenia. , 2002, The American journal of psychiatry.

[41]  J. Sweeney,et al.  Negative symptom resolution and improvements in specific cognitive deficits after acute treatment in first-episode schizophrenia , 2002, Schizophrenia Research.

[42]  R. Murray,et al.  Schizophrenia: a neurodevelopmental or neurodegenerative disorder? , 2002 .

[43]  J. Lieberman,et al.  The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches , 2001, Biological Psychiatry.

[44]  Daniel R. Weinberger,et al.  Prefrontal neurons and the genetics of schizophrenia , 2001, Biological Psychiatry.

[45]  John Polich,et al.  P300 asymmetry in schizophrenia: a meta-analysis , 2001, Psychiatry Research.

[46]  Patricia Desmond,et al.  A longitudinal study of hippocampal volume in first episode psychosis and chronic schizophrenia , 2001, Schizophrenia Research.

[47]  P. Styles,et al.  Developmental and regional distribution of aspartoacylase in rat brain tissue , 2001, Journal of neurochemistry.

[48]  F. Jessen,et al.  Amplitude reduction of the mismatch negativity in first-degree relatives of patients with schizophrenia , 2001, Neuroscience Letters.

[49]  Adrian M. Owen,et al.  Cognitive Deficits in Brain Disorders , 2001 .

[50]  L. Rangel,et al.  Childhood chronic fatigue syndrome. , 2001, The American journal of psychiatry.

[51]  A. Malla,et al.  Untreated initial psychosis. , 2001, The American journal of psychiatry.

[52]  W. Kaiser,et al.  Cerebral phosphate metabolism in first-degree relatives of patients with schizophrenia. , 2001, The American journal of psychiatry.

[53]  S. Lawrie,et al.  Brain structure, genetic liability, and psychotic symptoms in subjects at high risk of developing schizophrenia , 2001, Biological Psychiatry.

[54]  R. McCarley,et al.  A review of MRI findings in schizophrenia , 2001, Schizophrenia Research.

[55]  N. Andreasen,et al.  Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia , 2001, Biological Psychiatry.

[56]  J. Cohen,et al.  Selective deficits in prefrontal cortex function in medication-naive patients with schizophrenia. , 2001, Archives of general psychiatry.

[57]  R. Buchanan,et al.  A separate disease within the syndrome of schizophrenia. , 2001, Archives of general psychiatry.

[58]  Alessandro Bertolino,et al.  The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia , 2001, Biological Psychiatry.

[59]  D. Javitt,et al.  Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia. , 2000, Archives of general psychiatry.

[60]  J. Lieberman,et al.  Deficits in auditory and visual context-dependent processing in schizophrenia: defining the pattern. , 2000, Archives of general psychiatry.

[61]  A. Caspi,et al.  Children's self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study. , 2000, Archives of general psychiatry.

[62]  C. Pantelis,et al.  Evidence for progression of brain structural abnormalities in schizophrenia: beyond the neurodevelopmental model. , 2000, The Australian and New Zealand journal of psychiatry.

[63]  R. Coppola,et al.  Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. , 2000, Cerebral cortex.

[64]  P. Liddle,et al.  Immediate effects of risperidone on cortico–striato–thalamic loops and the hippocampus , 2000, British Journal of Psychiatry.

[65]  P. McGorry,et al.  Insight in psychosis. , 2000, The Harvard mental health letter.

[66]  R. McCarley,et al.  Lateralized P3 deficit in schizotypal personality disorder , 2000, Biological Psychiatry.

[67]  Walter Ritter,et al.  Associated deficits in mismatch negativity generation and tone matching in schizophrenia , 2000, Clinical Neurophysiology.

[68]  M. Keshavan,et al.  Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings—part II , 2000, Biological Psychiatry.

[69]  M. Egan,et al.  Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect. , 2000, Archives of general psychiatry.

[70]  Matcheri S Keshavan,et al.  Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings–part I , 2000, Biological Psychiatry.

[71]  I. Gottesman,et al.  Attention, memory, and motor skills as childhood predictors of schizophrenia-related psychoses: the New York High-Risk Project. , 2000, The American journal of psychiatry.

[72]  M. Baslow,et al.  Functions of N‐Acetyl‐l‐Aspartate and N‐Acetyl‐l‐Aspartylglutamate in the Vertebrate Brain , 2000, Journal of neurochemistry.

[73]  J. Lieberman,et al.  Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. , 2000, The American journal of psychiatry.

[74]  Tyrone D. Cannon,et al.  P300 subcomponent abnormalities in schizophrenia: III. Deficits in unaffected siblings of schizophrenic probands , 2000, Biological Psychiatry.

[75]  Margaret Niznikiewicz,et al.  The effect of family status and schizotypy on electrophysiologic measures of attention and semantic processing , 2000, Biological Psychiatry.

[76]  Adolf Pfefferbaum,et al.  Trait and state aspects of p300 amplitude reduction in schizophrenia: a retrospective longitudinal study , 2000, Biological Psychiatry.

[77]  G. Jackson,et al.  Neurobiological findings in early phase schizophrenia , 2000, Brain Research Reviews.

[78]  Dieter F. Braus,et al.  Effects of age, medication, and illness duration on the N-acetyl aspartate signal of the anterior cingulate region in schizophrenia , 2000, Schizophrenia Research.

[79]  P. Maruff,et al.  Magnetic Resonance Spectroscopy and Schizophrenia: What have we Learnt? , 2000, The Australian and New Zealand journal of psychiatry.

[80]  P. Maruff,et al.  The nature of the memory deficit in schizophrenia , 2000, Schizophrenia Research.

[81]  E. Bullmore,et al.  Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[82]  J. Newcomer,et al.  NMDA receptor hypofunction model of schizophrenia. , 1999, Journal of psychiatric research.

[83]  P. Falkai,et al.  Genetic and non-genetic vulnerability factors in schizophrenia: the basis of the "two hit hypothesis". , 1999, Journal of psychiatric research.

[84]  L. DeLisi,et al.  Longitudinal neuropsychological follow-up study of patients with first-episode schizophrenia. , 1999, The American journal of psychiatry.

[85]  N. Andreasen,et al.  Longitudinal study of cognitive function in first-episode and recent-onset schizophrenia. , 1999, The American journal of psychiatry.

[86]  E. Johnstone,et al.  Neuropsychological assessment of young people at high genetic risk for developing schizophrenia compared with controls: preliminary findings of the Edinburgh High Risk Study (EHRS) , 1999, Psychological Medicine.

[87]  M. Keshavan,et al.  Brain maturational processes and delayed onset in schizophrenia , 1999, Development and Psychopathology.

[88]  R. Kahn,et al.  Memory impairment in schizophrenia: a meta-analysis. , 1999, The American journal of psychiatry.

[89]  D. Arnold,et al.  Proton magnetic resonance spectroscopy for the diagnosis and management of cerebral disorders. , 1999, Archives of neurology.

[90]  Jane S. Paulsen,et al.  Generalized cognitive deficits in schizophrenia: a study of first-episode patients. , 1999, Archives of general psychiatry.

[91]  M Takigawa,et al.  Changes in levels of phosphorus metabolites in temporal lobes of drug-naive schizophrenic patients. , 1999, The American journal of psychiatry.

[92]  Robert Bartha,et al.  A short echo proton magnetic resonance spectroscopy study of the left mesial-temporal lobe in first-onset schizophrenic patients , 1999, Biological Psychiatry.

[93]  Steven Warach,et al.  Schizophrenic subjects activate dorsolateral prefrontal cortex during a working memory task, as measured by fMRI , 1999, Biological Psychiatry.

[94]  Karl J. Friston,et al.  Abnormal Cingulate Modulation of Fronto-Temporal Connectivity in Schizophrenia , 1999, NeuroImage.

[95]  P. Goldman-Rakic,et al.  Cortical dysfunction in schizophrenia during auditory word and tone working memory demonstrated by functional magnetic resonance imaging. , 1998, Archives of general psychiatry.

[96]  O Salonen,et al.  Regional gray matter, white matter, and cerebrospinal fluid distributions in schizophrenic patients, their siblings, and controls. , 1998, Archives of general psychiatry.

[97]  D. Javitt,et al.  Effects of clozapine on auditory event-related potentials in schizophrenia , 1998, Biological Psychiatry.

[98]  A. Catafau,et al.  The resting and activation issue of hypofrontality: a single photon emission computed tomography study in neuroleptic-naive and neuroleptic-free schizophrenic female patients , 1998, Biological Psychiatry.

[99]  T Sigmundsson,et al.  Brain changes in schizophrenia , 1998, British Journal of Psychiatry.

[100]  Konstantine K. Zakzanis,et al.  Neurocognitive Deficit in Schizophrenia: A Quantitative Review of the Evidence , 1998 .

[101]  G. Patton,et al.  Prediction of psychosis , 1998, British Journal of Psychiatry.

[102]  D J Mikulis,et al.  Cerebral gray matter volume deficits in first episode psychosis. , 1998, Archives of general psychiatry.

[103]  J. Coyle,et al.  Evidence for the presence of N-acetylaspartylglutamate in cultured oligodendrocytes and LPS activated microglia , 1998, Brain Research.

[104]  T. Robbins,et al.  Executive function in first-episode schizophrenia , 1998, Psychological Medicine.

[105]  Y. Hirayasu,et al.  Abnormalities of auditory event-related potentials in schizophrenia prior to treatment , 1998, Biological Psychiatry.

[106]  S. Lawrie,et al.  Brain abnormality in schizophrenia , 1998, British Journal of Psychiatry.

[107]  Tyrone D. Cannon,et al.  A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures. , 1998, Archives of general psychiatry.

[108]  Thomas E. Nichols,et al.  Anterior cingulate gyrus dysfunction and selective attention deficits in schizophrenia: [15O]H2O PET study during single-trial Stroop task performance. , 1997, The American journal of psychiatry.

[109]  Gregory G. Brown,et al.  Review of functional magnetic resonance imaging in schizophrenia , 1997, Schizophrenia Research.

[110]  R W Neufeld,et al.  Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy. , 1997, Archives of general psychiatry.

[111]  M S Buchsbaum,et al.  Decreased anterior cingulate gyrus metabolic rate in schizophrenia. , 1997, The American journal of psychiatry.

[112]  J. Ragland,et al.  Neuropsychological evidence supporting a neurodevelopmental model of schizophrenia: a longitudinal study , 1997, Schizophrenia Research.

[113]  R. M. Murray,et al.  The Maudsley Family Study, II: Endogenous event-related potentials in familial schizophrenia , 1997, Schizophrenia Research.

[114]  K O Lim,et al.  Cortical gray matter volume deficit in patients with first-episode schizophrenia. , 1996, The American journal of psychiatry.

[115]  M. Albus,et al.  Neuropsychological impairment in first-episode and chronic schizophrenic patients , 1996, European Archives of Psychiatry and Clinical Neuroscience.

[116]  C. Pantelis,et al.  What have We Learned from Functional Imaging Studies in Schizophrenia? the Role of Frontal, Striatal and Temporal Areas , 1996, The Australian and New Zealand journal of psychiatry.

[117]  J. Coyle,et al.  N-Acetylaspartate in neuropsychiatric disorders , 1995, Progress in Neurobiology.

[118]  P. Williamson,et al.  An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy. , 1995, Archives of general psychiatry.

[119]  S. Andrews,et al.  Brain potential evidence for an auditory sensory memory deficit in schizophrenia. , 1995, The American journal of psychiatry.

[120]  M. Keshavan,et al.  Changes in caudate volume with neuroleptic treatment , 1994, The Lancet.

[121]  J. Ford,et al.  ERPs in schizophrenia: Effects of antipsychotic medication , 1994, Biological Psychiatry.

[122]  R. Gur,et al.  Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. , 1994, Archives of general psychiatry.

[123]  Daniel R. Weinberger,et al.  Medial temporal lobe structures in schizophrenia: relationship of size to duration of illness , 1994, Schizophrenia Research.

[124]  D. Blackwood,et al.  Neuropsychological and P300 abnormalities in schizophrenics and their relatives , 1993, Psychological Medicine.

[125]  P. Rowlands Insight in psychosis , 1993, British Journal of Psychiatry.

[126]  D. Gadian,et al.  Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[127]  R Kikinis,et al.  Auditory P300 abnormalities and left posterior superior temporal gyrus volume reduction in schizophrenia. , 1993, Archives of general psychiatry.

[128]  T. Inubushi,et al.  Brain lithium concentrations measured with lithium-7 magnetic resonance spectroscopy in patients with affective disorders: Relationship to erythrocyte and serum concentrations , 1993, Biological Psychiatry.

[129]  J. Born,et al.  Event-related potential correlates of impaired selective attention in children at high risk for schizophrenia , 1992, Biological Psychiatry.

[130]  D. Weinberger,et al.  Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: a magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins. , 1992, The American journal of psychiatry.

[131]  L. DeLisi,et al.  Neuropsychological functioning of first-episode schizophreniform patients. , 1992, The American journal of psychiatry.

[132]  Early intervention with neuroleptics may decrease the long-term morbidity of schizophrenia Richard Jed Wyatt NIMH Neuroscience Center, Washington, DC 20032 , 1992, Biological Psychiatry.

[133]  R. Wyatt 13. Early intervention with neuroleptics may decrease the l long-term morbidity of schizophrenia , 1991, Schizophrenia Research.

[134]  J C Duffy,et al.  Auditory P300 and eye tracking dysfunction in schizophrenic pedigrees. , 1991, Archives of general psychiatry.

[135]  M. Keshavan,et al.  Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy. , 1991, Archives of general psychiatry.

[136]  P. Tueting Electrophysiology of schizophrenia. EEG and ERPs , 1991 .

[137]  M. Mintz,et al.  Event-related potentials in drug-naive schizophrenic patients , 1991, Biological Psychiatry.

[138]  Lynn W. Jelinski,et al.  Nuclear magnetic resonance spectroscopy. , 1990, Analytical chemistry.

[139]  S. Siris,et al.  Implications of normal brain development for the pathogenesis of schizophrenia. , 1988, Archives of general psychiatry.

[140]  S. Stahl,et al.  Computed tomographic evidence for generalized sulcal and ventricular enlargement in schizophrenia. , 1988, Archives of general psychiatry.

[141]  R. Murray,et al.  Is schizophrenia a neurodevelopmental disorder? , 1987, British medical journal.

[142]  J. Strauss,et al.  The Vermont longitudinal study of persons with severe mental illness, II: Long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia. , 1987, The American journal of psychiatry.

[143]  R Kono,et al.  Antibody titres to enterovirus type 70 in the 1981 Indian epidemic of acute haemorrhagic conjunctivitis. , 1981, Lancet.

[144]  D. Weinberger,et al.  Structural abnormalities in the cerebral cortex of chronic schizophrenic patients. , 1979, Archives of general psychiatry.

[145]  T. Crow,et al.  CEREBRAL VENTRICULAR SIZE AND COGNITIVE IMPAIRMENT IN CHRONIC SCHIZOPHRENIA , 1976, The Lancet.

[146]  Stephan Arndt,et al.  Untreated initial psychosis: relation to cognitive deficits and brain morphology in first-episode schizophrenia. , 2003, The American journal of psychiatry.

[147]  J. Sweeney,et al.  Prolonged untreated illness duration from prodromal onset predicts outcome in first episode psychoses. , 2003, Schizophrenia bulletin.

[148]  N. Minshew,et al.  Prefrontal membrane phospholipid metabolism of child and adolescent offspring at risk for schizophrenia or schizoaffective disorder: an in vivo 31P MRS study , 2003, Molecular Psychiatry.

[149]  N. Minshew,et al.  Prefrontal membrane phospholipid metabolism of child and adolescent offspring at risk for schizophrenia or schizoaffective disorder: an in vivo 31P MRS study , 2003, Molecular Psychiatry.

[150]  H. Sauer,et al.  Hypofrontality in neuroleptic-naive schizophrenic patients during the Wisconsin Card Sorting Test – a fMRI study , 2001, European Archives of Psychiatry and Clinical Neuroscience.

[151]  C. Pantelis,et al.  Stability of olfactory identification deficits in neuroleptic-naive patients with first-episode psychosis. , 2001, The American journal of psychiatry.

[152]  R. Kahn,et al.  Volumes of brain structures in twins discordant for schizophrenia. , 2001, Archives of general psychiatry.

[153]  A. Jablensky Course and outcome of schizophrenia and their prediction , 2000 .

[154]  J A Frank,et al.  Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia. , 2000, The American journal of psychiatry.

[155]  H. Meltzer,et al.  The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. , 1999, Schizophrenia bulletin.

[156]  R. Heinrichs,et al.  Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. , 1998, Neuropsychology.

[157]  G C Patton,et al.  Monitoring and care of young people at incipient risk of psychosis. , 1996, Schizophrenia bulletin.

[158]  T. Barnes,et al.  Schizophrenia : a neuropsychological perspective , 1996 .

[159]  T. McGlashan,et al.  Early detection and intervention in schizophrenia: research. , 1996, Schizophrenia bulletin.

[160]  S. Kugelmass,et al.  Neuropsychological assessment of attention and its pathology in the Israeli cohort. , 1995, Schizophrenia bulletin.

[161]  D Friedman,et al.  Event-related potentials (ERPs) as indicators of risk for schizophrenia. , 1994, Schizophrenia bulletin.

[162]  M E Shenton,et al.  P300 topographic asymmetries are present in unmedicated schizophrenics. , 1993, Electroencephalography and clinical neurophysiology.

[163]  M. Keshavan,et al.  First-episode studies in schizophrenia: criteria and characterization. , 1992, Schizophrenia bulletin.

[164]  I. Feinberg Cortical pruning and the development of schizophrenia. , 1990, Schizophrenia bulletin.

[165]  K. Lim,et al.  Differing effects of duration of illness on CT findings in alcoholism and schizophrenia. , 1988, Psychopharmacology bulletin.

[166]  S. Weintraub Risk factors in schizophrenia: the Stony Brook High-Risk Project. , 1987, Schizophrenia bulletin.

[167]  D. Garver Methodological issues facing the interpretation of high-risk studies: biological heterogeneity. , 1987, Schizophrenia bulletin.

[168]  I. Feinberg,et al.  Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? , 1982, Journal of psychiatric research.